ITRM Stock: Institutional Buying Squeezes Shorts Out of Iterum

Iterum Therapeutics ITRM Stock News

Iterum Therapeutics PLC (NASDAQ: ITRM) is flying in the market this morning, squeezing the shorts out of their positions after a disclosure showed a large stake in the company was taken by RA Capital Management. Here’s what’s going on: Skip to What You Want to Read RA Capital Management Takes Stake in Iterum Therapeutics Shorts … Read more

OCGN Stock: Ocugen Climbs on Offering at a Premium

Ocugen OCGN Stock News

Ocugen Inc (NASDAQ: OCGN) is screaming for the top in the market this morning, and for good reason. The company announced that it’s raising funds. However, unlike many fundraise efforts seen in the biotechnology category, this raise is happening at a premium to the market price as of the announcement of the transaction. Here’s what’s … Read more

TTOO Stock: T2 Biosystems Climbs on COVID News

T2 Biosystems TTOO Stock News

T2 Biosystems Inc (NASDAQ: TTOO) is screaming for the top in the market this morning, and for good reason. The company announced that its diagnostic test can detect variants of the virus that causes COVID-19. Here’s what’s going on: Skip to What You Want to Read T2 Biosystems Announces COVID-19 Testing News Management Commentary Why … Read more

TNXP Stock: Here’s Why Tonix Pharmaceuticals Is Up

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is headed for the top in the premarket hours this morning, trading on gains of over 25%. If you’re looking for press releases or SEC filings, you’ll be hard-pressed to find anything. Nonetheless, there’s a couple of good reasons for the gains.  First off, it seems as though TNXP … Read more

TYME Stock: TYME Technologies Heads up on COVID-19 News

Tyme Technologies TYME Stock News

Tyme Technologies Inc (NASDAQ: TYME) is screaming for the top in the market this morning, and for good reason. The company announced that it has been awarded a patent surrounding methods for treating COVID-19. Here’s what’s happening: Skip to What You Want to Read Tyme Technologies Announces COVID-19 News Why Investors Are So Excited Is … Read more

MBRX Stock: Moleculin Announces 100% Survival

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is running for the top in the market this morning, trading on gains of nearly 100% after announcing that a preclinical treatment led to a 100% survival rate in animals with metastatic osteosarcoma. Here’s what’s going on: Skip to What You Want to Read Moleculin Biotech Announces Positive Oncology Data … Read more